Oncorus scores $79.5 mln Series B
Cambridge, Massachusetts-based Oncorus Inc, an oncolytic virus company, has raised $79.5 million in Series B financing. Cowen Healthcare Investments and Perceptive Advisors led the round.
21 August 2019•1 min read
Cambridge, Massachusetts-based Oncorus Inc, an oncolytic virus company, has raised $79.5 million in Series B financing. Cowen Healthcare Investments and Perceptive Advisors led the round.
